Literature DB >> 24693037

Genome organization, instabilities, stem cells, and cancer.

S Pazhanisamy1, V Jyothi2.   

Abstract

It is now widely recognized that advances in exploring genome organization provide remarkable insights on the induction and progression of chromosome abnormalities. Much of what we know about how mutations evolve and consequently transform into genome instabilities has been characterized in the spatial organization context of chromatin. Nevertheless, many underlying concepts of impact of the chromatin organization on perpetuation of multiple mutations and on propagation of chromosomal aberrations remain to be investigated in detail. Genesis of genome instabilities from accumulation of multiple mutations that drive tumorigenesis is increasingly becoming a focal theme in cancer studies. This review focuses on structural alterations evolve to raise a variety of genome instabilities that are manifested at the nucleotide, gene or sub-chromosomal, and whole chromosome level of genome. Here we explore an underlying connection between genome instability and cancer in the light of genome architecture. This review is limited to studies directed towards spatial organizational aspects of origin and propagation of aberrations into genetically unstable tumors.

Entities:  

Keywords:  Nuclear architecture; carcinogenesis; chromatin structure; chromosomal aberrations; genome instability; spatial organization; stem cells

Year:  2009        PMID: 24693037      PMCID: PMC3908152     

Source DB:  PubMed          Journal:  J Stem Cells Regen Med        ISSN: 0973-7154


  92 in total

1.  Dynamics of DNA double-strand breaks revealed by clustering of damaged chromosome domains.

Authors:  Jacob A Aten; Jan Stap; Przemek M Krawczyk; Carel H van Oven; Ron A Hoebe; Jeroen Essers; Roland Kanaar
Journal:  Science       Date:  2004-01-02       Impact factor: 47.728

Review 2.  Chromosome positioning in the interphase nucleus.

Authors:  Luis Parada; Tom Misteli
Journal:  Trends Cell Biol       Date:  2002-09       Impact factor: 20.808

3.  An AT-rich sequence in human common fragile site FRA16D causes fork stalling and chromosome breakage in S. cerevisiae.

Authors:  Haihua Zhang; Catherine H Freudenreich
Journal:  Mol Cell       Date:  2007-08-03       Impact factor: 17.970

Review 4.  Opinion: the origin of the cancer stem cell: current controversies and new insights.

Authors:  Rolf Bjerkvig; Berit B Tysnes; Karen S Aboody; Joseph Najbauer; A J A Terzis
Journal:  Nat Rev Cancer       Date:  2005-11       Impact factor: 60.716

5.  The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT-) type.

Authors:  G Ott; T Katzenberger; A Greiner; J Kalla; A Rosenwald; U Heinrich; M M Ott; H K Müller-Hermelink
Journal:  Cancer Res       Date:  1997-09-15       Impact factor: 12.701

6.  Distribution of u.v.-induced repair events in higher-order chromatin loops in human and hamster fibroblasts.

Authors:  L H Mullenders; A C van Kesteren; C J Bussmann; A A van Zeeland; A T Natarajan
Journal:  Carcinogenesis       Date:  1986-06       Impact factor: 4.944

7.  Constitutive fragile sites and cancer.

Authors:  J J Yunis; A L Soreng
Journal:  Science       Date:  1984-12-07       Impact factor: 47.728

8.  Mutator phenotypes in human colorectal carcinoma cell lines.

Authors:  N P Bhattacharyya; A Skandalis; A Ganesh; J Groden; M Meuth
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

Review 9.  Aneuploidy and cancer.

Authors:  Harith Rajagopalan; Christoph Lengauer
Journal:  Nature       Date:  2004-11-18       Impact factor: 49.962

10.  Chromosomal changes in uroepithelial carcinomas.

Authors:  Imad Fadl-Elmula
Journal:  Cell Chromosome       Date:  2005-08-07
View more
  1 in total

1.  High risk of benzo[α]pyrene-induced lung cancer in E160D FEN1 mutant mice.

Authors:  Zhenxing Wu; Yuanji Lin; Hong Xu; Huifang Dai; Mian Zhou; Sharlene Tsao; Li Zheng; Binghui Shen
Journal:  Mutat Res       Date:  2011-12-06       Impact factor: 2.433

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.